- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Pursuant to 10b5-1 trading plans entered into on March 27, 2007, the following officers of Harris & Harris Group, Inc., exercised vested stock options on May 14, 2007, that would have expired on June 26, 2007: Douglas W. Jamison, Alexei A. Andreev, Daniel V. Leff, Sandra M. Forman, Patricia N. Egan and Mary P. Brady. The total number of shares purchased through such exercises was 391,855 for $3,961,647. Of these 391,855 shares, on May 14, 2007, 367,989 were sold for a total of $4,564,805, and 23,866 shares were retained by the employees. Altogether, these employees increased their aggregate ownership of the Company's shares by 23,866 shares, from 36,357 shares to 60,223 shares.
The total $4,564,805 proceeds of the sales were used in the following manner.
|Purchase of 391,855 Shares||$||3,961,647|
|Through Exercise of Options|
|Taxes Withheld by the Company on||$||317,753|
|Exercises of Options|
|Net Cash Retained by Employees from Sales||$||266,831|
|Total Proceeds of Sales||$||4,564,805|
About Harris & Harris Group
Harris & Harris Group is a publicly traded venture capital company that makes initial investments exclusively in tiny technology, including nanotechnology, microsystems and microelectromechanical systems (MEMS). The Company's last 33 initial private equity investments have been in tiny technology-enabled companies. The Company has 21,732,884 shares of common stock outstanding.
Detailed information about Harris & Harris Group and its holdings can be found on its website at http://www.TinyTechVC.com .
This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release. Please see the Company's Registration Statement on Form N-2 and Annual Report on Form 10-K for the year ended December 31, 2006, filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including but not limited to the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, Harris & Harris Group, Inc., undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties. The reference to the website http://www.TinyTechVC.com has been provided as a convenience, and the information contained on such website is not incorporated by reference into this press release.
For more information, please click here
Harris & Harris Group, Inc.
Charles E. Harris, 212-582-0900
Copyright © Business Wire 2007If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Graphenea embarks on a new era April 16th, 2015
Graphenea celebrates fifth anniversary April 27th, 2015